Skip to content
Disclosery

Broadfin Capital, LLC

Follow

13F filer, CIK 1511901, New York, NY

Broadfin Capital, LLC reported $459,647,000 across 39 holdings for the quarter ended 2019-06-30, in a 13F-HR filed 2019-08-14. Its ten largest share positions make up 60.98% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001511901-19-000005

Period
2019-06-30
Reported value
$460M
Holdings
39
Top 10 weight
60.98%
New
9
Sold out
13

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ALLERGAN PLCnew+114,804$19.2M
BIOHAVEN PHARMACEUTICAL HOL…added+429,979$18.8M
EIGER BIOPHARMACEUTICALS INCadded+1,462,837$15.5M
SIENTRA INCnew+1,400,000$8.62M
HRTXadded+450,000$8.37M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
IOVAreduced-2,769,004-$67.9M
ADAMAS PHARMACEUTICALS INCreduced-2,028,806-$12.6M
ACRSexited-2,030,925-$12.2M
CPRXreduced-3,091,928-$11.9M
MIRATI THERAPEUTICS INCexited-148,100-$10.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2019

Share positions as resolved from 13F-HR 0001511901-19-000005, largest first. % of portfolio is the value over $406,613,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 912,987 shares; 2018Q2: 4,146,605 shares; 2018Q3: 4,894,361 shares; 2018Q4: 5,951,153 shares; 2019Q1: 4,328,303 shares; 2019Q2: 1,559,299 shares 1,559,299$38.2M9.4%-2,769,004Timeline
ARATANA THERAPEUTICS INCARATANA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 4,294,426 shares; 2018Q2: 4,294,426 shares; 2018Q3: 4,083,135 shares; 2018Q4: 4,083,135 shares; 2019Q1: 7,258,135 shares; 2019Q2: 7,258,135 shares 7,258,135$37.5M9.21%0
NEVRO CORPNEVRO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 744,415 shares; 2019Q1: 622,615 shares; 2019Q2: 488,265 shares 488,265$31.7M7.78%-134,350
BIOHAVEN PHARMACEUTICAL HOL…BIOHAVEN PHARMACEUTICAL HOLDINQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 129,300 shares; 2019Q1: 246,900 shares; 2019Q2: 676,879 shares 676,879$29.6M7.29%+429,979
RETROPHIN INCRETROPHIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,178,226 shares; 2018Q2: 1,048,693 shares; 2018Q3: 938,214 shares; 2018Q4: 1,016,114 shares; 2019Q1: 1,016,114 shares; 2019Q2: 1,053,314 shares 1,053,314$21.2M5.2%+37,200
BIODELIVERY SCIENCES INTL INBIODELIVERY SCIENCES INTL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 4,278,819 shares; 2018Q2: 4,278,819 shares; 2018Q3: 4,375,066 shares; 2018Q4: 4,375,066 shares; 2019Q1: 4,375,066 shares; 2019Q2: 4,281,943 shares 4,281,943$19.9M4.9%-93,123
ALLERGAN PLCALLERGAN PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 114,804 shares 114,804$19.2M4.73%new
EIGER BIOPHARMACEUTICALS INCEIGER BIOPHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 143,300 shares; 2019Q1: 193,300 shares; 2019Q2: 1,656,137 shares 1,656,137$17.6M4.32%+1,462,837
GLOBAL BLOOD THERAPEUTICS U…GLOBAL BLOOD THERAPEUTICS USDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 80,100 shares; 2018Q3: not reported; 2018Q4: 240,909 shares; 2019Q1: 395,309 shares; 2019Q2: 316,619 shares 316,619$16.7M4.1%-78,690
ZOGENIX INC.ZOGENIX INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 537,380 shares; 2018Q2: 622,380 shares; 2018Q3: 657,898 shares; 2018Q4: 535,998 shares; 2019Q1: 371,698 shares; 2019Q2: 344,762 shares 344,762$16.5M4.05%-26,936
SOCIETAL CDMO INCSOCIETAL CDMO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,236,025 shares; 2018Q2: 2,048,025 shares; 2018Q3: 2,048,025 shares; 2018Q4: 2,048,025 shares; 2019Q1: 1,909,995 shares; 2019Q2: 1,561,617 shares 1,561,617$15.9M3.91%-348,378
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,581,416 shares; 2018Q2: 519,787 shares; 2018Q3: 291,213 shares; 2018Q4: 119,294 shares; 2019Q1: 207,998 shares; 2019Q2: 657,998 shares 657,998$12.2M3.01%+450,000Timeline
CPRXCATALYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 6,812,764 shares; 2018Q2: 6,772,764 shares; 2018Q3: 5,136,264 shares; 2018Q4: 6,268,298 shares; 2019Q1: 5,856,998 shares; 2019Q2: 2,765,070 shares 2,765,070$10.6M2.61%-3,091,928Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 24,200 shares; 2018Q4: 179,900 shares; 2019Q1: 67,500 shares; 2019Q2: 63,300 shares 63,300$9.48M2.33%-4,200Timeline
AVADEL PHARMACEUTICALS, PLCAVADEL PHARMACEUTICALS, PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,624,663 shares; 2018Q2: 2,724,663 shares; 2018Q3: 2,792,773 shares; 2018Q4: 3,102,673 shares; 2019Q1: 3,102,673 shares; 2019Q2: 3,102,673 shares 3,102,673$8.97M2.21%0
SIENTRA INCSIENTRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 1,400,000 shares 1,400,000$8.62M2.12%new
LA JOLLA PHARMACEUTICAL COLA JOLLA PHARMACEUTICAL COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,656,720 shares; 2018Q2: 1,494,520 shares; 2018Q3: 2,053,991 shares; 2018Q4: 1,947,541 shares; 2019Q1: 1,994,911 shares; 2019Q2: 891,760 shares 891,760$8.25M2.03%-1,103,151
STRATA SKIN SCIENCES INCSTRATA SKIN SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 203,346 shares; 2018Q2: 2,943,819 shares; 2018Q3: 2,181,363 shares; 2018Q4: 2,171,363 shares; 2019Q1: 2,866,323 shares; 2019Q2: 3,256,615 shares 3,256,615$8.11M1.99%+390,292
STRONGBRIDGE BIOPHARMA PLCSTRONGBRIDGE BIOPHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,793,752 shares; 2018Q2: 2,340,649 shares; 2018Q3: 2,563,096 shares; 2018Q4: 2,821,722 shares; 2019Q1: 2,792,049 shares; 2019Q2: 2,544,839 shares 2,544,839$7.96M1.96%-247,210
VRAYQVIEWRAY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 250,000 shares; 2018Q4: 866,500 shares; 2019Q1: 866,500 shares; 2019Q2: 866,500 shares 866,500$7.63M1.88%0Timeline
SOL GEL TECHNOLOGIESSOL GEL TECHNOLOGIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 647,700 shares; 2018Q2: 647,700 shares; 2018Q3: 847,700 shares; 2018Q4: 847,700 shares; 2019Q1: 847,700 shares; 2019Q2: 730,100 shares 730,100$6.65M1.64%-117,600
SIBNSI BONE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 312,898 shares 312,898$6.36M1.57%newTimeline
QUOTIENT LTDQUOTIENT LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 439,700 shares; 2018Q3: 804,700 shares; 2018Q4: 1,697,582 shares; 2019Q1: 1,098,656 shares; 2019Q2: 639,756 shares 639,756$5.98M1.47%-458,900
ANTARES PHARMA INCANTARES PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 4,673,247 shares; 2018Q2: 4,623,247 shares; 2018Q3: 4,623,247 shares; 2018Q4: 3,444,147 shares; 2019Q1: 2,643,947 shares; 2019Q2: 1,744,147 shares 1,744,147$5.74M1.41%-899,800
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 183,300 shares; 2019Q1: 100,000 shares; 2019Q2: 66,600 shares 66,600$5.66M1.39%-33,400Timeline
AMARIN CORP PLCAMARIN CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,078,799 shares; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 291,000 shares 291,000$5.64M1.39%new
VCELVERICEL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 658,900 shares; 2018Q2: not reported; 2018Q3: 132,600 shares; 2018Q4: 190,000 shares; 2019Q1: 272,550 shares; 2019Q2: 258,150 shares 258,150$4.88M1.2%-14,400Timeline
OPTINOSE INCOPTINOSE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 710,600 shares; 2019Q1: 585,600 shares; 2019Q2: 595,900 shares 595,900$4.22M1.04%+10,300
WRIGHT MED GROUP N VWRIGHT MED GROUP N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 126,400 shares 126,400$3.77M0.93%new
MYGNMYRIAD GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: 240,000 shares; 2019Q2: 123,785 shares 123,785$3.44M0.85%-116,215Timeline
ADMAADMA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 720,529 shares; 2018Q2: 3,249,829 shares; 2018Q3: 4,463,829 shares; 2018Q4: 4,226,077 shares; 2019Q1: 1,479,243 shares; 2019Q2: 747,500 shares 747,500$2.89M0.71%-731,743Timeline
ADAMAS PHARMACEUTICALS INCADAMAS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,135,203 shares; 2018Q2: 1,417,121 shares; 2018Q3: 1,328,424 shares; 2018Q4: 2,614,468 shares; 2019Q1: 2,469,894 shares; 2019Q2: 441,088 shares 441,088$2.73M0.67%-2,028,806
NANOSTRING TECHNOLOGIES INCNANOSTRING TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 850,000 shares; 2018Q4: 720,600 shares; 2019Q1: 355,714 shares; 2019Q2: 74,786 shares 74,786$2.27M0.56%-280,928
MATINAS BIOPHARMA HLDGS INCMATINAS BIOPHARMA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: 2,727,272 shares; 2019Q2: 766,708 shares 766,708$657K0.16%-1,960,564

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INC COMcall200,000$20.6Mnew
BIOHAVEN PHARMACEUTICAL HOL…BIOHAVEN PHARMACEUTICAL HOLDIN COMcall400,000$17.5Mnew
RETROPHIN INCRETROPHIN INC COMput500,000$10Mnew
RETROPHIN INCRETROPHIN INC COMcall150,000$3.01Mnew
HRTXHERON THERAPEUTICS INC COMcall100,000$1.86M-300,000

Sold out in Q2 2019

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MYGNMYRIAD GENETICS INC500,000$16.6Mcall
ACRSACLARIS THERAPEUTICS INC2,030,925$12.2Mshares
MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INC148,100$10.9Mshares
INTERSECT ENT INCINTERSECT ENT INC263,500$8.47Mshares
SIERRA ONCOLOGY INCSIERRA ONCOLOGY INC4,829,832$8.26Mshares
IARTINTEGRA LIFESCIENCES HLDGS C141,572$7.89Mshares
LIVNLIVANOVA PLC48,000$4.67Mshares
NEOS THERAPEUTICS INCNEOS THERAPEUTICS INC1,611,999$4.21Mshares
TELIGENT INC NEWTELIGENT INC NEW1,990,983$2.31Mshares
ATECALPHATEC HLDGS INC442,966$1.17Mshares
OPIANT PHARMACEUTICALS INCOPIANT PHARMACEUTICALS INC85,484$1.12Mshares
RVLPQRVL PHARMACEUTICALS PLC ORDINA307,854$1.11Mshares
NOVELION THERAPEUTICS INCNOVELION THERAPEUTICS INC729,301$897Kshares

How Q2 2019 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001511901-19-000005 base2019-08-14acceptance time not in the bulk data set